메뉴 건너뛰기




Volumn 81, Issue 2, 2013, Pages 294-296

Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib

Author keywords

ALK translocation; Double mutation; EGFR mutation; Gefitinib; Neoadjuvant chemotherapy; Non small cell lung cancer

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB;

EID: 84879884193     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.009     Document Type: Article
Times cited : (34)

References (26)
  • 1
    • 84862302379 scopus 로고    scopus 로고
    • Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials
    • May (5)
    • Yu Y., Xu X., Du Z., Shi M. Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. Cancer Chemother Pharmacol 2012, 69(May (5)):1265-1275.
    • (2012) Cancer Chemother Pharmacol , vol.69 , pp. 1265-1275
    • Yu, Y.1    Xu, X.2    Du, Z.3    Shi, M.4
  • 2
    • 84867195295 scopus 로고    scopus 로고
    • Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? A literature meta-analysis
    • Xu C., Zhou Q., Wu Y. Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? A literature meta-analysis. J Hematol Oncol 2012, 5:62.
    • (2012) J Hematol Oncol , vol.5 , pp. 62
    • Xu, C.1    Zhou, Q.2    Wu, Y.3
  • 3
    • 0142055937 scopus 로고    scopus 로고
    • Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial
    • Kris M.G., Natale R.B., Herbst R.S., Lynch T.J., Prager D., Belani C.P., et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. J Am Med Assoc 2003, 290:2149-2158.
    • (2003) J Am Med Assoc , vol.290 , pp. 2149-2158
    • Kris, M.G.1    Natale, R.B.2    Herbst, R.S.3    Lynch, T.J.4    Prager, D.5    Belani, C.P.6
  • 4
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3    Gurubhagavatula, S.4    Okimoto, R.A.5    Brannigan, B.W.6
  • 5
    • 80052793410 scopus 로고    scopus 로고
    • A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
    • Sasaki T., Koivunen J., Ogino A., Yanagita M., Nikiforow S., Zheng W., et al. A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res 2011, 71:6051-6060.
    • (2011) Cancer Res , vol.71 , pp. 6051-6060
    • Sasaki, T.1    Koivunen, J.2    Ogino, A.3    Yanagita, M.4    Nikiforow, S.5    Zheng, W.6
  • 6
    • 84870297371 scopus 로고    scopus 로고
    • Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas
    • Dai Z., Kelly J.C., Meloni-Ehrig A., Slovak M.L., Boles D., Christacos N.C., et al. Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas. Mol Cytogenet 2012, 5:44.
    • (2012) Mol Cytogenet , vol.5 , pp. 44
    • Dai, Z.1    Kelly, J.C.2    Meloni-Ehrig, A.3    Slovak, M.L.4    Boles, D.5    Christacos, N.C.6
  • 7
    • 34547638047 scopus 로고    scopus 로고
    • Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    • Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
    • (2007) Nature , vol.448 , pp. 561-566
    • Soda, M.1    Choi, Y.L.2    Enomoto, M.3    Takada, S.4    Yamashita, Y.5    Ishikawa, S.6
  • 8
    • 84868204403 scopus 로고    scopus 로고
    • Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma
    • May
    • Ren S., Chen X., Kuang P., Zheng L., Su C., Li J., et al. Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma. Cancer 2012, 8(May).
    • (2012) Cancer , vol.8
    • Ren, S.1    Chen, X.2    Kuang, P.3    Zheng, L.4    Su, C.5    Li, J.6
  • 9
    • 81755161162 scopus 로고    scopus 로고
    • Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer
    • [abstr 10517]
    • Yang J., Zhang X., Su J., Chen H., Tian H., Huang J., et al. Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer. J Clin Oncol 2011, 29(Suppl.). [abstr 10517].
    • (2011) J Clin Oncol , vol.29 , Issue.SUPPL.
    • Yang, J.1    Zhang, X.2    Su, J.3    Chen, H.4    Tian, H.5    Huang, J.6
  • 10
    • 84865089246 scopus 로고    scopus 로고
    • Analysis of receptor tyrosine kinase ROS1 positive tumors in non small cell lung cancer: identification of a FIG-ROS1 fusion
    • August (16)
    • Rimkunas V.M., Crosby E., Li Daiqiang, Hu Y., Kelly M.E., Gu T.L., et al. Analysis of receptor tyrosine kinase ROS1 positive tumors in non small cell lung cancer: identification of a FIG-ROS1 fusion. Clin Cancer Res 2012, 18(August (16)):4449-4457.
    • (2012) Clin Cancer Res , vol.18 , pp. 4449-4457
    • Rimkunas, V.M.1    Crosby, E.2    Daiqiang, L.3    Hu, Y.4    Kelly, M.E.5    Gu, T.L.6
  • 12
    • 34548849132 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method
    • September
    • Pao W., Ladanyi M. Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res 2007, 13(September):4954.
    • (2007) Clin Cancer Res , vol.13 , pp. 4954
    • Pao, W.1    Ladanyi, M.2
  • 13
    • 84875074252 scopus 로고    scopus 로고
    • The role of molecular pathology in non small cell lung carcinoma-now and in the future
    • June (Suppl. 1)
    • Brandao G.D.A., Brega E.F., Spatz A. The role of molecular pathology in non small cell lung carcinoma-now and in the future. Curr Oncol. 2012, 19(June (Suppl. 1)):S24-S32.
    • (2012) Curr Oncol. , vol.19
    • Brandao, G.D.A.1    Brega, E.F.2    Spatz, A.3
  • 14
    • 84874606355 scopus 로고    scopus 로고
    • EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumor tissue and cytology samples
    • Ellison G., Zhu G., Moulis A., Dearden S., Speake G., McCormack R EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumor tissue and cytology samples. J Clin Pathol 2013, 66(2):79-89.
    • (2013) J Clin Pathol , vol.66 , Issue.2 , pp. 79-89
    • Ellison, G.1    Zhu, G.2    Moulis, A.3    Dearden, S.4    Speake, G.5    McCormack, R.6
  • 15
    • 36849065315 scopus 로고    scopus 로고
    • Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
    • Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
    • (2007) Cell , vol.131 , pp. 1190-1203
    • Rikova, K.1    Guo, A.2    Zeng, Q.3    Possemato, A.4    Yu, J.5    Haack, H.6
  • 16
    • 80051784751 scopus 로고    scopus 로고
    • Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression
    • Kim H., Yoo S.B., Choe J.Y., et al. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. J Thorac Oncol 2011, 6:1359-1366.
    • (2011) J Thorac Oncol , vol.6 , pp. 1359-1366
    • Kim, H.1    Yoo, S.B.2    Choe, J.Y.3
  • 17
    • 67650441507 scopus 로고    scopus 로고
    • Anaplasic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non small cell lung carcinomas
    • Boland J.M., Erdogan S., Vasmatzis G., et al. Anaplasic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non small cell lung carcinomas. Hum Pathol 2009, 40:1153-1158.
    • (2009) Hum Pathol , vol.40 , pp. 1153-1158
    • Boland, J.M.1    Erdogan, S.2    Vasmatzis, G.3
  • 20
    • 80051780280 scopus 로고    scopus 로고
    • Initial phase II results with crizotinib in advanced ALK positive non small cell lung cancer (NSCLC): PROFILE 1005
    • 2011 ASCO Annual meeting [abstr 7514]
    • Crinò L., Kim G., Riely G.J., Janne P.A., et al. Initial phase II results with crizotinib in advanced ALK positive non small cell lung cancer (NSCLC): PROFILE 1005. J Clin Oncol 2011, 29(Suppl.). 2011 ASCO Annual meeting [abstr 7514].
    • (2011) J Clin Oncol , vol.29 , Issue.SUPPL.
    • Crinò, L.1    Kim, G.2    Riely, G.J.3    Janne, P.A.4
  • 21
    • 78650499456 scopus 로고    scopus 로고
    • Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
    • December (12)
    • Kuo Y.W., Wu S.G., Ho C.C., Shih J.Y. Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation. J Thorac Oncol 2010, 5(December (12)):2039-2040.
    • (2010) J Thorac Oncol , vol.5 , pp. 2039-2040
    • Kuo, Y.W.1    Wu, S.G.2    Ho, C.C.3    Shih, J.Y.4
  • 22
    • 80054911665 scopus 로고    scopus 로고
    • Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib
    • Popat S., Vieira de Araújo A., Min T., Swansbury J., Dainton M., Wotherspoon A., et al. Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. J Thorac Oncol 2011, 6:1962.
    • (2011) J Thorac Oncol , vol.6 , pp. 1962
    • Popat, S.1    Vieira de Araújo, A.2    Min, T.3    Swansbury, J.4    Dainton, M.5    Wotherspoon, A.6
  • 23
    • 78650950138 scopus 로고    scopus 로고
    • EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations
    • Tiseo M., Gelsomino F., Boggiani D., Bortesi B., Bartolotti M., Bozzetti C., et al. EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations. Lung Cancer 2011, 71:241-243.
    • (2011) Lung Cancer , vol.71 , pp. 241-243
    • Tiseo, M.1    Gelsomino, F.2    Boggiani, D.3    Bortesi, B.4    Bartolotti, M.5    Bozzetti, C.6
  • 24
    • 84863776935 scopus 로고    scopus 로고
    • Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation
    • Lee J.K., Kim T.M., Koh Y., Lee S.H., Kim D.W., Jeon Y.K., et al. Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. Lung Cancer 2012, 77:460-463.
    • (2012) Lung Cancer , vol.77 , pp. 460-463
    • Lee, J.K.1    Kim, T.M.2    Koh, Y.3    Lee, S.H.4    Kim, D.W.5    Jeon, Y.K.6
  • 25
    • 84869886632 scopus 로고    scopus 로고
    • A case of lung cancer adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
    • Tanaka H., Hayashi A., Morimoto T., Taima K., Tanaka Y., Shimada M., et al. A case of lung cancer adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene. BMC Cancer 2012, 12:558.
    • (2012) BMC Cancer , vol.12 , pp. 558
    • Tanaka, H.1    Hayashi, A.2    Morimoto, T.3    Taima, K.4    Tanaka, Y.5    Shimada, M.6
  • 26
    • 79951773393 scopus 로고    scopus 로고
    • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    • Jianjigian Y.Y., Park B.J., Zakowoski M.F., Ladanyi M., Pao W., D'Angelo S.P., et al. Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations. J Thorac Oncol 2011, 6:569-575.
    • (2011) J Thorac Oncol , vol.6 , pp. 569-575
    • Jianjigian, Y.Y.1    Park, B.J.2    Zakowoski, M.F.3    Ladanyi, M.4    Pao, W.5    D'Angelo, S.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.